Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.17
Delayed Data
As of Aug 04
 -0.16 / -2.53%
Today’s Change
3.71
Today|||52-Week Range
10.20
+35.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash1.5M4.4M2.3M1.8M
 
 
 
 
 
Short Term Investment Cash313.7K2.9M-2.2M-510.0K
 
 
 
 
 
Cash & Short Term Investments3.7M5.1M8.5M21.3M
 
 
 
 
 
 
ReceivablesReceivables567.1K172.7K153.0K408.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.7K2.3K----
 
 
 
Other Current Assets0.000.000.0064.0K
 
 
Current Assets4.3M5.3M8.6M21.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross123.5K125.6K130.3K144.0K
 
 
 
 
 
Depreciation-106.1K-120.8K-124.5K-130.0K
 
 
 
 
 
Other Assets24.5K12.6K7.5K7.0K
 
 
 
 
 
Total Assets4.3M5.3M8.7M21.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable386.3K628.0K439.5K--
 
 
 
 
Accrued Expenses------973.0K
 
 
Other Current Liabilities18.5K0.000.00973.0K
 
 
 
Other Liabilities441.3K644.4K498.2K973.0K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities0.00637.2K0.000.00
 
 
Total Liabilities602.0K1.5M529.4K1.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity3.7M3.8M8.1M20.8M
 
 
 
 
 
Total Shareholder Equity3.7M3.8M8.1M20.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding5.8M6.7M7.9M10.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.